Fighting antibiotic resistance: Boehringer Ingelheim joins AMR Action FundCompany contributes USD 50 million to invest in antibiotic R&D within AMR Action FundAntimicrobial resistance (AMR) considered one of the most urgent global medical challengesJoint approach to combat the global threat of AMR 
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news
More News: Research